Infarmed suspends sale of the antidepressant Sertraline toLife

Monday, 26 January 2026RSS
Infarmed suspends sale of the antidepressant Sertraline toLife

Infarmed states that the laboratory will recall the nine batches of Sertraline toLife 50 mg and 100 mg products, after an impurity “above the acceptable limit” was detected.

Context & Explainers

Infarmed (Autoridade Nacional do Medicamento e Produtos de Saúde) is Portugal’s national regulator for medicines and health products that approves drugs, monitors safety and enforces rules on pricing and reimbursement. In 2025 it approved 928 new medicines — 79% were generics, 38 were designated essential and 236 were national products — which affects which medicines are available and how much they cost at pharmacies.

View full article on Observador

RSS source